Supplementary Materials
Published: 10 September 2021| Version 1 | DOI: 10.17632/9gb9z7832b.1
Contributor:
Jinhua XuDescription
Supplementary Materials for "A Multi-Center, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study Evaluating Efficacy and Safety of Vunakizumab in Patients with Moderate-to-Severe Plaque Psoriasis"
Files
Categories
Clinical Trial, Psoriasis